Expedited research and approval of medicines for drug-resistant bacterial infections in children.
Multidrug-resistant pathogens cause severe infections with substantial morbidity and mortality in neonates, infants and children, as they do in adults. However, the approval of therapies for multidrug-resistant infections in paediatric patients often lags years behind approval for adults, which crea...
| Publicado en: | Bulletin of the World Health Organization Vol. 104; no. 8; pp. 551 - 560 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | tables/charts Journal Article |
| Publicado: |
World Health Organization
Aug2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |